News Seminars

Clinical Co-governance of improving integrative cancer care in the private sector

Joint Online Seminar by Department of English and Communication and International Research Centre for the Advancement of Health Communication

Date: 13 Jan 2023

Time: 4 pm – 5pm (UTC+8)


Cancer accounts for the highest mortality in the world with 1 out of 6 of death related to its prevalence or cancer-related complications. With the last resort, Chinese Herbal Medicine (CHM) is the most common form of complementary and alternative medicine (CAM) among patients in the United States (14.2%), China (55%) and Taiwan (64%). TCM is already widely accepted by mainland Chinese physicians due to the history, culture, and politics of the People’s Republic of China, with 98% having received TCM training. Hong Kong is a window to bridge clinical practice to the global context. Thus, the experience gained in this study must be able to advance global multi-disciplinary medical industry for recommendation. 

This talk takes top down and bottom-up approaches to discuss a model of integrative medicine in cancer care. This will help in identifying perceived gaps in the treatment and collaboration among cancer patients, their caregivers, oncologists, nurse, administrator, pharmacist, dispensary and Chinese Medicine Practitioners. The results will help guide strategies to improve patient-centered actions relating to cancer treatment and survivorship.

This was the first in depth case study to investigate the cancer care from physician and patients in Hong Kong on both industries. A patient-centered approach has been used to analyse the priorities of the care in current process of care. The success of the model could be determined by the 1) number of enrolled patients; 2) a clinical audit; 3) the liver, renal functions or blood report of cancer patients before or after this medical care; 4) patients’ satisfaction of the medical service or 5) internal staff of evaluation of the process of care.  The analysis considered of the effectiveness, safety, adverse effect, drug-related symptoms, or cost, that was explored from the key stakeholders of the medical industry in Hong Kong.  With the global trend of Integrative Medicine, this study could facilitate inter-professional communication for improving the clinical management of cancer in Chinese in the private sector.

About the Speaker

Dr. Wendy Wong, PhD, BCM, BSc (Hons.), is the Director of Dr Wendy Wong’s Clinic, Honorary Professor of the National Institute of Disease Prevention and Body constitution, Beijing University of Chinese Medicine. Her research interests include Traditional Chinese Medicine, Patients reported outcomes of Chinese, Body constitution, Primary Healthcare, Randomized clinical trials of Integrative Medicine, Chinese Medicine cancer treatments, and Interdisciplinary Communication.